NDC product
Carbidopa, Levodopa, and Entacapone
NDC 0781-5641 · Sandoz Inc
Key facts
| Product NDC | 0781-5641 |
|---|---|
| Proprietary name | Carbidopa, Levodopa, and Entacapone |
| Nonproprietary name | Carbidopa, Levodopa, and Entacapone |
| Substances | CARBIDOPA, LEVODOPA, ENTACAPONE |
| Dosage form | TABLET, FILM COATED |
| Route | ORAL |
| Labeler | Sandoz Inc |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Application number | NDA021485 |
| Pharmacologic classes | Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC], Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC] |
| Marketing start | Jun 18, 2014 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: